상세 보기
Subcutaneous Daratumumab (DARA) plus Bortezomib, Cyclophosphamide, and Dexamethasone (VCd) in Patients with Newly Diagnosed Light Chain (AL) Amyloidosis: Overall Survival and Final Major Organ Deterioration Progression-Free Survival Results from the Phase 3 Andromeda Study
- Kastritis, Efstathios;
- Palladini, Giovanni O.;
- Minnema, Monique C.;
- Wechalekar, Ashutosh D.;
- Jaccard, Arnaud;
- ... Kim, Kihyun;
- 외 24명
Citations
WEB OF SCIENCE
8Citations
SCOPUS
0- 제목
- Subcutaneous Daratumumab (DARA) plus Bortezomib, Cyclophosphamide, and Dexamethasone (VCd) in Patients with Newly Diagnosed Light Chain (AL) Amyloidosis: Overall Survival and Final Major Organ Deterioration Progression-Free Survival Results from the Phase 3 Andromeda Study
- 저자
- Kastritis, Efstathios; Palladini, Giovanni O.; Minnema, Monique C.; Wechalekar, Ashutosh D.; Jaccard, Arnaud; Lee, Hans C.; Sanchorawala, Vaishali; Mollee, Peter; Lu, Jin; Schoenland, Stefan; Gatt, Moshe E.; Suzuki, Kenshi; Kim, Kihyun; Cibeira, Teresa; Bhutani, Manisha; Beksac, Meral; Libby, Edward; Valent, Jason; Hungria, Vania; Rosenzweig, Michael; Bumma, Naresh; Huart, Antoine; Tran, Namphuong; Wang, Jianping; Chen, Yuping; Vasey, Sandra Y.; Schecter, Jordan M.; Vermeulen, Jessica; Comenzo, Raymond L.; Merlini, Giampaolo
- 발행일
- 2024-11-05
- 유형
- Meeting Abstract
- 저널명
- Blood
- 권
- 144
- 페이지
- 891 ~ 893